Empagliflozin Impact on Hemodynamics in Patients With Heart Failure
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mikhail Kosiborod, MD
Saint Luke's Mid America Heart Institute
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Southern California
Los Angeles, California, United States
- First Coast Cardiovascular Institute
Jacksonville, Florida, United States
- Northshore University Health System Research Institute
Evanston, Illinois, United States
- Centracare Heart and Vascular Center
Saint Cloud, Minnesota, United States
- St. Francis Hospital
Roslyn, New York, United States
- Ohio State University
Columbus, Ohio, United States
- Sanford Research
Sioux Falls, South Dakota, United States
- Austin Heart Clinical Research
Austin, Texas, United States
- Baylor College of Medicine
Houston, Texas, United States
- Sentara Cardiovascular Research Institute
Norfolk, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Jul 2017
- Primary completion
- 10 Mar 2020
- Completion
- 10 Mar 2020
- Last update posted
- 9 Dec 2021
- Registered enrollment
- 65
- Registry id
- NCT03030222
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.